David A Seidman, M.D. Otolaryngology - Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 116-24 Metropolitan Avenue, 2 Flr, Richmond Hill, NY 11418 Phone: 718-805-9500 Fax: 718-847-9457 |
News Archive
Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, announced that it has received CE Mark for the treatment of Left Main Coronary artery disease. With this approval, Tryton Medical becomes the first company to earn a CE Mark for this indication.
Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced it has entered into an agreement with Piscataway, N.J.-based University of Medicine and Dentistry of New Jersey (UMDNJ) to conducted a Phase 1 clinical trial with its proprietary, patent-pending mobilization technology UMK-121 in patients with end-stage liver disease (ESLD).
The severity of knee joints damage in soccer players depends on their age and career duration, and the condition of articular cartilage and meniscus of the dominant (which has a higher mechanical load) and the non-dominant leg does not differ.
Cryoprotectants needed to preserve eggs for reproduction need to be given in stages, albeit rapid ones, say scientists who have developed a mathematical model that predicts optimal time for loading and unloading these drugs.
A new research paper recently uploaded to the preprint server bioRxiv by Jesse D. Bloom et al. (22nd Feb 2021) aims to map all of the currently circulating SARS-CoV-2 lineages with resistance towards LY-CoV555 and LY-CoV016, and document the specific mutations that confer resistance, ultimately suggesting that future monoclonal antibody cocktails should target a more diverse range of epitopes.
› Verified 4 days ago